New & Notable
AMPEL develops a blood test for cardiovascular disease
Armie Grammer, AMPEL's co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company's CardioGENE blood test for cardiovascular disease risk.
Vaccines are key in cutting antimicrobial resistance, costs
WHO's report emphasizes vaccines in fighting antimicrobial resistance. Broader vaccine access could save thousands of lives, reduce antibiotic use and cut global healthcare costs.
Role of advanced modeling and virtual data in drug approvals
Advanced modeling and virtual data help biopharma companies design efficient, ethical and cost-effective trials to accelerate drug development and regulatory approvals.
Iowa resident dies of suspected Lassa fever after travel
The investigation into the death of an Iowa resident suspected to have contracted Lassa fever in West Africa might identify the ninth case of Lassa virus in the U.S. since 1969.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All ReportsHealthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
TreeHouse Foods expands recall of waffles, pancakes
TreeHouse Foods expands its recall of waffles and pancakes from major retailers, like Walmart, Target, Aldi, Dollar General, Kroger, Publix, Whole Foods, Trader Joe's and more.
-
Hurricane Helene triggers dialysis and IV fluid shortage
Following Hurricane Helene, damages to a manufacturing plant in North Carolina and subsequent nationwide IV fluid shortages have forced manufacturers to mobilize global networks.
-
Medicare drug price negotiations impact non-chain pharmacies
Although Medicare drug price negotiations intend to expand medication access, independent pharmacies are facing challenges associated with reimbursement and PBM strategies.
-
PBMs call for FTC commissioners' recusal from antitrust case
Cigna, UnitedHealth and CVS Caremark are requesting FTC commissioners step down from a PBM lawsuit, alleging prejudgment and bias in the agency's review process.
-
FDA authorizes combined at-home flu, COVID-19 tests outside EUA
The Healgen Rapid Check COVID-19/Flu A&B Antigen Test is the first combined at-home flu and COVID tests to be authorized by the FDA through traditional premarket review.
-
WHO clears in vitro diagnostic mpox testing for emergency use
After declaring a global health emergency for mpox, the WHO has issued an Emergency Use Listing for an in vitro diagnostic test for early mpox diagnosis and treatment.
Features
-
Addressing gene and cell therapy commercialization challenges
InspiroGene addresses some gene and cell therapy commercialization challenges by offering logistics programs, distribution services, a biologics specialty pharmacy and a patient hub.
-
Advancing sustainability in biopharmaceutical manufacturing
Sustainable biopharmaceutical manufacturing is adopting green technologies to minimize waste, optimize processes and uphold product quality amid regulatory and environmental challenges.
-
Understanding PMBs' role and impact on drug pricing
PBMs shape drug pricing and healthcare costs, but growing market consolidation sparks concerns about less competition, higher prices and fewer options for patients.
-
Exploring emerging breast cancer screening tools, technology
New breast cancer screening tools, ranging from 3D mammography to AI-assisted screening analysis play a critical role in the evolving breast cancer screening landscape.